See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Jean Hoffman profile image

Jean Hoffman

Board Member at Argenta
Intro Book
Seasoned executive with pharmaceutical industry expertise and leadership experience.
  • Claim this Profile
Location
Portland, Maine Metropolitan Area, US
Languages
  • English Native or bilingual proficiency
  • Chinese (Mandarin) Professional working proficiency
  • French Elementary proficiency
Skills
  • Strategy
  • Pharmaceutical Industry
  • Leadership
  • Strategic Planning
  • Fda
  • Show all
image
image

Refer a Friend to Get
100 Credits For FREE

Refer a Friend Now

Bio

Generated by
Topline AI
Jean Hoffman is a seasoned executive with a strong background in strategy, leadership, and pharmaceutical industry expertise. She has held various leadership positions, including Board Member at Argenta, MedRhythms, Inc., Finance Authority of Maine (FAME), Casco Bay Lines Island Transit District, Q Street Advisors LLC, The Jackson Laboratory, Golden Springs Group, Putney, Inc., and Newport Strategies, Inc. She has also led turnaround strategies for companies like Zetapharm, Inc. and Zuellig Group N.A., Inc. Jean holds an Executive MBA from Stanford University and has completed various executive education courses from Harvard Business School and Columbia University.

Experience

  • Argenta
    • United Kingdom
    • Board Member
      • Aug 2021 - Present
      • United Kingdom

      Argenta is a combined global contract research organization (CRO) and contract development and manufacturing organization (CDMO) dedicated to animal health, headquartered in the UK, with operations in Germany, Spain, New Zealand, the US and the UK.

  • MedRhythms, Inc.
    • Portland, ME
    • Board Member
      • Feb 2017 - Present
      • Portland, ME

      A digital therapeutics (DTx) company that uses sensors, music, and AI to build prescription, evidence-based, neurologic interventions to measure and improve walking.

  • Finance Authority of Maine (FAME)
    • Augusta, Maine, United States
    • Board Member
      • Oct 2022 - Present
      • Augusta, Maine, United States

  • Casco Bay Lines Island Transit District
    • Portland, Maine
    • Elected Board Member
      • Nov 2021 - Present
      • Portland, Maine

      Elected to represent Peaks Island and work with other Island representatives to oversee the ferry service to the residential islands of Casco Bay.

  • Q Street Advisors LLC
    • Portland, Maine Area
    • Managing Member
      • May 2016 - Present
      • Portland, Maine Area

  • The Jackson Laboratory
    • Maine
    • Member Board Of Trustees, Audit and Enterprise Risk Management Committee Chair
      • Aug 2018 - Dec 2022
      • Maine

      JAX, a global research organization, bridges the gap between mouse and human data to drive biological discovery and accelerate translation to the clinic. Chaired the Audit and Enterprise Risk Management Committee, Member Finance and Strategy Committees.

  • Golden Springs Group
    • Singapore
    • Board Member
      • Feb 2019 - May 2020
      • Singapore

      Holding company for Regal Springs Tilapia, SyAqua Shrimp genetics & others

  • Putney, Inc.
    • Portland, Maine
    • Chairman, President and CEO
      • Mar 2006 - Apr 2016
      • Portland, Maine

      Founded, chaired board of directors and led Putney as president and CEO from founding to a $200mm sale that closed in April 2016. Recruited an extraordinary team. We built Putney to be the leading generic pharmaceutical company focused on drugs for pets.

  • Q Street Advisors, Inc.
    • President
      • Sep 2004 - Dec 2006

      Strategic consulting and transaction advisory services for the global generic pharmaceutical and API sectors.

  • Newport Strategies, Inc.
    • Portland, Maine Area
    • Founder and President
      • 1990 - 2004
      • Portland, Maine Area

      Founded in 1990 and built company into the world leader in product targeting and sourcing systems for the global generic pharmaceutical industry. Newport was acquired by Thomson Reuters in 2004.

  • Zetapharm, Inc.
    • Greater New York City Area
    • President and Director
      • 1987 - 1989
      • Greater New York City Area

      Turn around strategy for Zuellig owned supplier of APIs for Rx and OTC drugs to the generic pharmaceutical industry.

  • Zuellig Group N.A., Inc.
    • Greater New York City Area
    • General Manager, Far East
      • 1984 - 1986
      • Greater New York City Area

      Led all China Business Development activities for Zuellig companies world-wide.

  • ZetaPharm, Inc.
    • Greater New York City Area
    • Manager, China Business
      • 1982 - 1983
      • Greater New York City Area

      Joined Zuellig owned US API company to lead China strategy and BD efforts for OTC and veterinary drugs.

  • US-China Business Council
    • Washington D.C. Metro Area
    • Assistant Director of Importer Services
      • Apr 1980 - Apr 1982
      • Washington D.C. Metro Area

      Advised executives of US companies on China strategy and Chinese entities on how to export to the US, focused on pharmaceutical and chemical industries.

Education

  • 1975 - 1979
    Bowdoin College
    BA, East Asian History; Gov't & Legal Studies
  • 2012 - 2012
    Harvard Business School
    Executive Ed
  • Stanford University
    EPGC, Executive MBA Program for Growing Cos. - 1997
  • Columbia University - Columbia Business School

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Pharmaceuticals and Healthcare.”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles